Aventis Pharma ltd t/a Sanofi

Large enterpriseMedical equipment

Has won 94 UK public-sector contracts worth £1.0bn across 7 buyers, primarily NHS England and medical equipment work.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£734.4m

▲ 5491% vs prior 12m

Public buyers

94 contracts total

Top buyer share

86%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 86% of revenue.

NHS England

£907.1m

86%

Department of Health and Social Care (DHSC)

£142.3m

14%

UK Health Security Agency

£1

The NHS Commissioning Board (operating under the name of NHS England)

—

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

Contracts won · 94 total · 68 active · 24 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£403.7m lot total · 104 suppliers	13 Jan 2026	pending
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products	NHS England	Shared contract	£321.3m lot total · 8 suppliers	28 Nov 2025	pending
Contract for the supply of DTaP/IPV/Hib+HepB	Department of Health and Social Care (DHSC)	Shared contract	£89.3m lot total · 2 suppliers	19 Nov 2020	expired
Covid-19 Flu Vaccine Buffer Stock	Department of Health and Social Care (DHSC)	Framework call off	£47.0m ceiling · ~£47.0m share	15 Jun 2020	expired
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins	NHS England	Direct contract	£23.3m	14 Jul 2023	expired
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024	NHS England	Shared contract	£17.6m lot total · 39 suppliers	26 Jan 2024	active
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche	NHS England	Shared contract	£13.7m lot total · 35 suppliers	13 Feb 2023	expired
NHS Framework Agreement, Branded Medicines for London and South of England	NHS England	Framework call off	£13.3m ceiling · ~£317k share (÷42)	19 Aug 2021	expired
NHS Branded Medicines Tranche Framework for London and South of England	NHS England	Shared contract	£13.1m lot total · 29 suppliers	22 Jul 2024	active
NHS Framework Agreement for South of England Branded - Tranche B and Annual	NHS England	Direct contract	£11.7m	15 Jul 2022	expired
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024	NHS England	Shared contract	£11.2m lot total · 90 suppliers	05 Apr 2024	active
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National	NHS England	Shared contract	£9.4m lot total · 28 suppliers	25 Jun 2025	active
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche	NHS England	Shared contract	£9.0m lot total · 29 suppliers	08 Feb 2023	expired
Adult Infuenza Vaccines - Secondary Care	NHS England	Shared contract	£8.5m lot total · 2 suppliers	18 Aug 2021	expired
NHS Framework for the North of England, Branded Medicine	NHS England	Framework call off	£7.7m ceiling · ~£249k share (÷31)	07 Feb 2022	expired

Showing 1–15 of 94

Aventis Pharma ltd t/a Sanofi

Buyer concentration

Contracts won · 94 total · 68 active · 24 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Peer suppliers

News mentions

Aventis Pharma ltd t/a Sanofi

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive